FIELD: medicine.
SUBSTANCE: invention represents a topical and external pharmaceutical composition for treatment of purulent-destructive mucosal and skin diseases, and also sistemic diseases in immunodeficiency states characterised by the fact that it contains tilorone, a base and at least one target additive in a certain component relation, wt %. The target additive is specified from: immunomodulator, analgesic, cytostatic or their mixture.
EFFECT: reduced latent period of action of the composition, extended application of tilorone, higher effectiveness of the preparations based on the offered pharmaceutical composition, ease of application, reinforcement to treatment.
15 cl, 34 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ACRIDONACETIC ACID AND ITS COMPOUNDS FOR TREATMENT OF SUPPURATIVE-DESTRUCTIVE LESIONS OF MUCOUS MEMBRANE AND SKIN, GENERAL SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY STATES | 2008 |
|
RU2404773C2 |
| PHARMACEUTICAL INJECTION TILORONE-BASED COMPOSITION FOR TREATMENT OF DISEASES WITH IMMUNODEFICIENCY SIGNS | 2007 |
|
RU2364390C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
| PHARMACEUTICAL INJECTION COMPOSITION ON BASIS OF TILORONE FOR TREATMENT OF PURULENT-DESTRUCTIVE PROCESSES WITH SIGNS OF IMMUNE INSUFFICIENCY | 2007 |
|
RU2359664C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION ON BASIS OF LOW-MOLECULAR INDUCTOR OF INTERFERON | 2007 |
|
RU2352330C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
